Aligos Therapeutics Inc (ALGS)

16.21 -0.17  -1.04% NASDAQ Oct 27, 16:00 16.21 0.00  0.00% After-Hours: 16:03 USD
View Full Chart
Price Chart
View All ALGS News

News

View All Events

Events

Date Type Description
11/25/2021 Earnings Results Q3 2021 Earnings Results
08/05/2021 Earnings Results Q2 2021 Earnings Results
06/17/2021 11:30 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
03/23/2021 Earnings Results Q4 2020 Earnings Results
11/25/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
  • URL: https://www.aligos.com
  • Investor Relations URL: https://investor.aligos.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Nov. 25, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.